These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30823485)

  • 21. Fusion to Flaviviral Leader Peptide Targets HIV-1 Reverse Transcriptase for Secretion and Reduces Its Enzymatic Activity and Ability to Induce Oxidative Stress but Has No Major Effects on Its Immunogenic Performance in DNA-Immunized Mice.
    Latanova A; Petkov S; Kuzmenko Y; Kilpeläinen A; Ivanov A; Smirnova O; Krotova O; Korolev S; Hinkula J; Karpov V; Isaguliants M; Starodubova E
    J Immunol Res; 2017; 2017():7407136. PubMed ID: 28717654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant HCV core protein and the secretion of associated cytokines (IL-6, TNF-α and IFN-γ) in immunized mice.
    Torbati E; Ghassab RK; Davachi ND
    Pak J Biol Sci; 2013 Dec; 16(24):2041-5. PubMed ID: 24517026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A truncated variant of the hepatitis C virus core induces a slow but potent immune response in mice following DNA immunization.
    Dueñas-Carrera S; Alvarez-Lajonchere L; Alvarez-Obregón JC; Herrera A; Lorenzo LJ; Pichardo D; Morales J
    Vaccine; 2000 Nov; 19(7-8):992-7. PubMed ID: 11115726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells.
    Deng X; Rui W; Zhang F; Ding W
    Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
    Alvarez-Lajonchere L; Shoukry NH; Grá B; Amador-Cañizares Y; Helle F; Bédard N; Guerra I; Drouin C; Dubuisson J; González-Horta EE; Martínez G; Marante J; Cinza Z; Castellanos M; Dueñas-Carrera S
    J Viral Hepat; 2009 Mar; 16(3):156-67. PubMed ID: 19017255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A truncated HCV core protein elicits a potent immune response with a strong participation of cellular immunity components in mice.
    Alvarez-Obregón JC; Dueñas-Carrera S; Valenzuela C; Grillo JM
    Vaccine; 2001 Jul; 19(28-29):3940-6. PubMed ID: 11427269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of plasmid DNA on immunogenicity of HBsAg-anti-HBs complex.
    Qu D; Yuan ZH; He LF; Yang L; Li GD; Wen YM
    Viral Immunol; 1998; 11(2):65-72. PubMed ID: 9765028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.
    Fujinaga H; Tsutsumi T; Yotsuyanagi H; Moriya K; Koike K
    Oncology; 2011; 81 Suppl 1():11-7. PubMed ID: 22212930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.
    Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM
    J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization.
    Encke J; zu Putlitz J; Stremmel W; Wands JR
    Arch Virol; 2003 Mar; 148(3):435-48. PubMed ID: 12607097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity.
    Ohba K; Yoshida S; Zahidunnabi Dewan M; Shimura H; Sakamaki N; Takeshita F; Yamamoto N; Okuda K
    Vaccine; 2007 May; 25(21):4291-300. PubMed ID: 17403560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Wands JR
    J Immunol; 1997 Nov; 159(10):5107-13. PubMed ID: 9366440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient induction of mouse immune responses to hepatitis C virus by viral core protein-carrying attenuated Salmonella typhimurium.
    Liao XL; Ren H; Zhao P; Zhu SY; Cao J; Chen ZH; Zhao LJ; Pan W; Feitelson MA; Qui ZT
    Viral Immunol; 2007 Sep; 20(3):469-78. PubMed ID: 17931117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
    Vidalin O; Fournillier A; Renard N; Chen M; Depla E; Boucreux D; Brinster C; Baumert T; Nakano I; Fukuda Y; Liljeström P; Trépo C; Inchauspé G
    Virology; 2000 Oct; 276(2):259-70. PubMed ID: 11040118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of the immune response generated against hepatitis C virus envelope proteins after DNA vaccination with polyprotein-encoding plasmids.
    Dueñas-Carrera S; Alvarez-Lajonchere L; César Alvarez-Obregón J; Pérez A; Acosta-Rivero N; Vázquez DM; Martínez G; Viña A; Pichardo D; Morales J
    Biotechnol Appl Biochem; 2002 Jun; 35(3):205-12. PubMed ID: 12074699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains.
    Andersson HA; Singh RA; Barry MA
    Mol Ther; 2006 Feb; 13(2):338-46. PubMed ID: 16242998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity.
    Liu ZX; Nishida H; He JW; Lai MM; Feng N; Dennert G
    J Virol; 2002 Feb; 76(3):990-7. PubMed ID: 11773374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Tokushige K; Wands JR
    J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
    Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
    Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
    Hiranuma K; Tamaki S; Nishimura Y; Kusuki S; Isogawa M; Kim G; Kaito M; Kuribayashi K; Adachi Y; Yasutomi Y
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():187-193. PubMed ID: 9934701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.